New 'Smart Bomb' drug trial opens for Tough-to-Treat cancers
NCT ID NCT07439094
Summary
This study is testing a new drug called CKD-703 in people with advanced solid tumors and a specific type of lung cancer that has stopped responding to standard treatments. CKD-703 is designed to target cancer cells more precisely to try to shrink tumors while potentially causing fewer side effects. The main goals are to find a safe dose and see if the drug is effective for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.